Grifols (GRFS) announced that its plasma-protein based fibrin sealant, FS, for controlling surgical bleeding has received approval from the United States Food and Drug Administration, FDA, for ...
Grifols FS combines two plasma proteins, fibrinogen and thrombin, and is applied with Johnson & Johnson MedTech’s airless spray technology to rapidly form clots. The FS solution is now available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback